faster. better. fewer.


It’s the modern business mantra.  No one has more at stake in finding innovative solutions that drive better results than the pharmaceutical industry, and the customers who rely on those companies for their daily medication needs.

When a leading pharmaceutical company came to Ashland asking about bioavailability enhancement, Dr. Vivian Bi and her colleagues at Ashland’s lab in Wilmington, Delaware, got right to work.  The team was looking to solve the challenge of making the active ingredients in drugs dissolve easier so they can more readily enter the bloodstream and do their job. 

It’s not a unique problem.  Experts recognize that 90 percent of medications under development today have poor solubility.  In this case, it meant patients could need up to 18 capsules or tablets for an effective dosage.  It’s a prescription for problems, for both the patients and the pharmaceutical companies.  

Dr. Bi and the Ashland team focused on finding the polymer – or combination of polymers – that enhanced solubility without undesirable side effects.  Off-the-shelf answers clearly didn’t work on such a complicated problem. But a willingness to think innovatively did.  “Sometime in the lab, the typical technology does not work,” Dr. Bi notes.  “You need to go outside the conventional and entertain different ideas.” 

The result:  a single pill that doubled the exposure of the active ingredient in the body.

Faster results.  More effective product performance.  Fewer pills or tablets to take.  A solution that benefits the Ashland customer, and their customers, too.  


Read More >

体育彩票超级大乐透计算器 福利彩票湖北快三开奖 少儿围棋单机游戏 彩票甘肃快3开奖查询 云南快乐十分中奖查询 上海时时乐杀号软件 吉林十一选五快速开奖现场 七乐彩出书顺序号 湖北快3开奖时间表 梅西总进球数 山东群英会历史开奖 云南十一选五开奖今天走势 全天幸运飞艇在线 体育彩票七星彩走势图 天津11选5介绍